Zanubrutinib

(7S)-2-(4-Phenoxyphenyl)-7-[1-(prop-2-enoyl)piperidin-4-yl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-carboxamid

Stoffgruppe

Antineoplastisches Mittel (BTK-Inhibitor)